Full Title: Antisense Oligonucleotide Purification Process: Successes and Challenges During Scale-up Presented by Robert Gronke, Ph.D., Senior Principal Scientist, Technical Development, Biogen Recently, our first full scale GMP batch for an antisense oligonucleotide was manufactured in the newly built synthesis suite at Biogen. A four-step purification process was then carried out in the existing flexible volume manufacturing facility that, up until this point, has been used for manufacturing Biogen’s protein-based parenterals. This was our first test case to demonstrate that Biogen can manufacture ASOs safely, at scale, and achieve high purity and yield. Results are presented on the scalability of the ASO process from bench to GMP scale, highlighting successes and challenges faced with scale-up of the downstream ASO process.

Hora

15:00 - 16:00 hs GMT+1

Organizador

BioPharma Asia Magazine
Compartir
Enviar a un amigo
Mi email *
Email destinatario *
Comentario *
Repite estos números *
Control de seguridad
Mayo / 2020 1119 webinars
Lunes
Martes
Miércoles
Jueves
Viernes
Sábado
Domingo
Lun 27 de Mayo de 2020
Mar 28 de Mayo de 2020
Mié 29 de Mayo de 2020
Jue 30 de Mayo de 2020
Vie 01 de Mayo de 2020
Sáb 02 de Mayo de 2020
Dom 03 de Mayo de 2020
Lun 04 de Mayo de 2020
Mar 05 de Mayo de 2020
Mié 06 de Mayo de 2020
Jue 07 de Mayo de 2020
Vie 08 de Mayo de 2020
Sáb 09 de Mayo de 2020
Dom 10 de Mayo de 2020
Lun 11 de Mayo de 2020
Mar 12 de Mayo de 2020
Mié 13 de Mayo de 2020
Jue 14 de Mayo de 2020